Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

1.30
Delayed Data
As of Sep 19
 -0.05 / -3.70%
Today’s Change
1.10
Today|||52-Week Range
6.97
-69.05%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close1.35
Today’s open1.35
Day’s range1.30 - 1.35
Volume144,531
Average volume (3 months)359,163
Market cap$41.8M
Dividend yield--
Data as of 09/19/2017

Growth & Valuation

Earnings growth (last year)+39.68%
Earnings growth (this year)-0.64%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...-0.51-7.54%
CLBSCaladrius Bioscience...+0.01+0.26%
ALTAltimmune Inc+0.08+3.45%
ALPNAlpine Immune Scienc...-0.15-1.53%
Data as of 3:58pm ET, 09/19/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$23.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts